Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.
Rengo G, Zincarelli C, Femminella GD, Liccardo D, Pagano G, de Lucia C, Altobelli GG, Cimini V, Ruggiero D, Perrone-Filardi P, Gao E, Ferrara N, Lymperopoulos A, Koch WJ, Leosco D. Rengo G, et al. Among authors: leosco d. Br J Pharmacol. 2012 Aug;166(8):2348-61. doi: 10.1111/j.1476-5381.2012.01954.x. Br J Pharmacol. 2012. PMID: 22452704 Free PMC article.
Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.
Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, Filippelli A, Ferrara N, Lisanti MP, Koch WJ, Lymperopoulos A. Rengo G, et al. Among authors: leosco d. Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2032-8. doi: 10.1152/ajpheart.00702.2009. Epub 2010 Mar 19. Am J Physiol Heart Circ Physiol. 2010. PMID: 20304818 Free article.
Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
Rengo G, Cannavo A, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Komici K, Parisi V, Scala O, Agresta A, Rapacciuolo A, Perrone Filardi P, Ferrara N, Koch WJ, Trimarco B, Femminella GD, Leosco D. Rengo G, et al. Among authors: leosco d. Circ Heart Fail. 2013 Nov;6(6):1259-67. doi: 10.1161/CIRCHEARTFAILURE.113.000329. Epub 2013 Sep 12. Circ Heart Fail. 2013. PMID: 24029661
β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.
Cannavo A, Liccardo D, Lymperopoulos A, Gambino G, D'Amico ML, Rengo F, Koch WJ, Leosco D, Ferrara N, Rengo G. Cannavo A, et al. Among authors: d amico ml, leosco d. J Pharmacol Exp Ther. 2016 Feb;356(2):503-13. doi: 10.1124/jpet.115.228411. Epub 2015 Nov 24. J Pharmacol Exp Ther. 2016. PMID: 26604244 Free PMC article.
Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure.
de Lucia C, Gambino G, Petraglia L, Elia A, Komici K, Femminella GD, D'Amico ML, Formisano R, Borghetti G, Liccardo D, Nolano M, Houser SR, Leosco D, Ferrara N, Koch WJ, Rengo G. de Lucia C, et al. Among authors: d amico ml, leosco d. Circ Heart Fail. 2018 Mar;11(3):e004153. doi: 10.1161/CIRCHEARTFAILURE.117.004153. Circ Heart Fail. 2018. PMID: 29535114 Free PMC article.
Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
Rengo G, Lymperopoulos A, Zincarelli C, Femminella G, Liccardo D, Pagano G, de Lucia C, Cannavo A, Gargiulo P, Ferrara N, Perrone Filardi P, Koch W, Leosco D. Rengo G, et al. Among authors: leosco d. Br J Pharmacol. 2012 Aug;166(8):2430-40. doi: 10.1111/j.1476-5381.2012.01972.x. Br J Pharmacol. 2012. PMID: 22519418 Free PMC article.
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.
Leosco D, Rengo G, Iaccarino G, Golino L, Marchese M, Fortunato F, Zincarelli C, Sanzari E, Ciccarelli M, Galasso G, Altobelli GG, Conti V, Matrone G, Cimini V, Ferrara N, Filippelli A, Koch WJ, Rengo F. Leosco D, et al. Cardiovasc Res. 2008 May 1;78(2):385-94. doi: 10.1093/cvr/cvm109. Epub 2007 Dec 18. Cardiovasc Res. 2008. PMID: 18093988
GRK2 as a novel gene therapy target in heart failure.
Rengo G, Lymperopoulos A, Leosco D, Koch WJ. Rengo G, et al. Among authors: leosco d. J Mol Cell Cardiol. 2011 May;50(5):785-92. doi: 10.1016/j.yjmcc.2010.08.014. Epub 2010 Aug 25. J Mol Cell Cardiol. 2011. PMID: 20800067 Free PMC article. Review.
[From bench to bedside: new insights into the treatment of heart failure].
Rengo G, Femminella GD, Liccardo D, de Lucia C, Pirozzi E, Pagano G, Mattiello G, Gargiulo P, Vitagliano A, Cirillo AP, Aruta SF, Allocca E, Leosco D, Perrone-Filardi P. Rengo G, et al. Among authors: leosco d. G Ital Cardiol (Rome). 2012 Apr;13(4):254-62. doi: 10.1714/1056.11557. G Ital Cardiol (Rome). 2012. PMID: 22495642 Review. Italian.
Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside.
Rengo G, Perrone-Filardi P, Femminella GD, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Marsico F, Lymperopoulos A, Leosco D. Rengo G, et al. Among authors: leosco d. Circ Heart Fail. 2012 May 1;5(3):385-91. doi: 10.1161/CIRCHEARTFAILURE.112.966895. Circ Heart Fail. 2012. PMID: 22589366 Review. No abstract available.
164 results